Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Receivables (2017 - 2026)

Organogenesis Holdings has reported Change in Receivables over the past 10 years, most recently at $51.5 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 484.71% year-over-year to $51.5 million; the TTM value through Dec 2025 reached $115.8 million, up 264.16%, while the annual FY2025 figure was $115.8 million, 264.16% up from the prior year.
  • Change in Receivables for Q4 2025 was $51.5 million at Organogenesis Holdings, up from $50.7 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $51.5 million in Q4 2025 and troughed at -$7.3 million in Q4 2023.
  • A 5-year average of $9.0 million and a median of $5.2 million in 2021 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: tumbled 166.42% in 2023 and later soared 1799.8% in 2025.
  • Year by year, Change in Receivables stood at $8.5 million in 2021, then plummeted by 132.21% to -$2.7 million in 2022, then tumbled by 166.42% to -$7.3 million in 2023, then skyrocketed by 220.6% to $8.8 million in 2024, then skyrocketed by 484.71% to $51.5 million in 2025.
  • Business Quant data shows Change in Receivables for ORGO at $51.5 million in Q4 2025, $50.7 million in Q3 2025, and $19.3 million in Q2 2025.